IF 2014
1.261
Logo


Welcome to the Annals of Transplantation

Annals of Transplantation is one of the fast-developing journals open to all scientists and fields of transplant medicine and related research. The journal is published quarterly and provides extensive coverage of the most important advances in transplantation.
Using an electronic on-line submission and peer review tracking system, Annals of Transplantation is committed to rapid review and publication. The average time... read more


Published: 2015-08-27

Metabolic Syndrome in Thai Renal Transplant Recipients: A Multicenter Study

Prajej Ruangkanchanasetr, Sakarn Bunnag, Attapong Vongwiwatana, Nalinee Premasathian, Yingyos Avihingsanon, Pongsathorn Gojaseni, Thanom Supaporn, Bancha Satirapoj

(Division of Nephrology, Phramongkutklao Hospital, Bangkok, Thailand)

Ann Transplant 2015; 20:500-505

DOI: 10.12659/AOT.893664


BACKGROUND: Many renal transplant recipients develop complications such as obesity, posttransplantation diabetes mellitus, and dyslipidemia. There have been few studies of metabolic syndrome (MS) in Asian renal transplant recipients.
MATERIAL AND METHODS: This cross-sectional study was performed in 303 patients in 5 transplant centers in Bangkok, Thailand. The diagnosis of MS was based on the criteria of the modified NCEP-ATPIII, and chronic allograft dysfunction was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m^2.
RESULTS: Of 303 recipients, MS was diagnosed in 94 cases (31.0%) and the prevalence of MS in the first 3 years and after 3 years posttransplantation were 21.4% and 34.7% (P=0.042), respectively. There was an association between advanced age and chronic allograft dysfunction and higher prevalence of MS. Regarding non-anti-hypertensive and non-hypoglycemic medications, m-TOR inhibitor (odds ratio [OR], 2.14; 95% CI, 1.02–4.5) was associated with the prevalence of MS. Multivariate analysis revealed MS was associated with the use of beta-blockers (OR, 3.17; 95% CI, 1.88–5.32). Patients with no MS components had 26.9% prevalence of chronic allograft dysfunction and patients with higher numbers of MS components had 87.5% prevalence of chronic allograft dysfunction, which was significantly different (P=0.022).
CONCLUSIONS: Our study revealed that the prevalence of MS was higher in patients with higher numbers of MS components, especially after 3 years posttransplantation. Presence of more components of MS was associated with worse renal function in renal transplant recipients.

Keywords: Allografts, Diabetes Mellitus, Glomerular Filtration Rate, metabolic syndrome, Obesity



Related Articles (0)

Coming Soon...

Published: 2015-08-25

Evaluation of Quality of Life Early and Late After Kidney Transplantation


Nurettin Ay, Melih Anıl, Vahhac Alp, Utkan Sevük, Bülent Dinç, Mustafa Çelik, Ramazan Danış

Ann Transplant 2015; 20:493-499

DOI: 10.12659/AOT.895139

Published: 2015-08-20

Mycophenolic Acid Metabolites Acyl-Glucuronide and Glucoside Affect the Occurrence of Infectious Complica...


Jolanta Zegarska, Ewa Hryniewiecka, Dorota Żochowska, Wlodzimierz Tszyrsznic, Radosław Jaźwiec, Agnieszka Borowiec, Emilia Pawłowska, Michał Dadlez, Leszek Pączek

Ann Transplant 2015; 20:483-492

DOI: 10.12659/AOT.894954